Orbis Medicines is based in Copenhagen, Denmark. It has raised $125M in total funding. Latest round: Series A.
Orbis Medicines is based in Copenhagen, Denmark. Orbis Medicines has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Orbis Medicines runs through 2025; nothing later has been disclosed. Investors on record include NEA (New Enterprise Associates), Eli Lilly and Company, Cormorant Asset Management, LP, Export and Investment Fund of Denmark (EIFO), Novo Holdings, Forbion. 6 distinct backers are named across the disclosed rounds.
We update the Orbis Medicines record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Copenhagen and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026